BEND, OR / ACCESSWIRE / April 7, 2015 / Med-Cannabis Pharma, Inc. (OTCQB: MCPI) announced that they have received approval for registration from the Medical Marijuana Dispensary Program (MMDP) for its new Lane County dispensary location.
Accomplishing this step renders this locations ability to open for business squarely on MCPI’s ability to meet the minimum requirements for a successful onsite assessment by the MMDP. Consistent with the forward looking planning and execution of MCPI’s concepts for this location, many of these requirements were being addressed as early as January of 2015.
Through the operation of its other dispensaries, MCPI is experienced in the MMDP requirements and procedures, giving the confidence to begin the build out of the new dispensary location while the application was being reviewed. By starting this process early; the build out, installation of security systems and safes, and other physical construction requirements, MCPI is in position to cut down on non-operational months of its dispensary that normally occur between registration approval and the final issuance of registration certificates by MMDP.
In addition to these physical requirements, business record, inventory tracking and safety procedures must be in place before MMDP will allow operation. MCPI is especially confident that these procedures will be in place swiftly, based on their in place procedures currently approved and in use at their other operational dispensaries in the state. By continuing to rely on considerable experience in owning and operating dispensaries, MCPI is poised to continue to implement its growth strategies in a bold and efficient manner; maximizing the ability to not only acquire, build and register new dispensary locations, but to successfully shepherd them into the operational and revenue generating stage as soon as possible.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. The Company does not undertake any duty nor does it intend to update the results of these forward-looking statements.
For more information please visit us at www.med-cannabispharma.com
Contact Information
GRACIELA MORENO?
President?
Med-Cannabis Pharma, Inc.?
+1 214 666 8364
SOURCE: Med-Cannabis Pharma, Inc.
